Enanta Pharmaceuticals
ENTA
#8720
Rank
S$0.28 B
Marketcap
S$9.83
Share price
-4.51%
Change (1 day)
-37.95%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): S-$3.11

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$3.11. In 2025 the company made an earnings per share (EPS) of S-$4.13 an increase over its 2024 EPS that were of S-$6.39.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$3.11-24.74%
2025S-$4.13-35.35%
2024S-$6.39
2021S-$6.4272.92%
2020S-$3.72-267.44%
2019S$2.22-61.35%
2018S$5.74147.22%
2017S$2.32-460%
2016S-$0.65-114.88%
2015S$4.33-23.81%
2014S$5.69-244.12%
2013S-$3.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$7.55-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$20.21-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA